{"DataElement":{"publicId":"3537196","version":"2","preferredName":"Person Hodgkin Lymphoma Malignant Neoplasm Diagnosis Category","preferredDefinition":"List of protocol defined categories specifically related to a patient's Hodgkin Lymphoma diagnosis.","longName":"HodCatSdyEnr","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3537090","version":"1","preferredName":"Person Hodgkin Lymphoma Malignant Neoplasm Diagnosis","preferredDefinition":"Information related to a patient's Hodgkin Lymphoma diagnosis.","longName":"2236731v1.0:3537088v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3537088","version":"1","preferredName":"Hodgkin Lymphoma Malignant Neoplasm Diagnosis","preferredDefinition":"A lymphoma, previously known as Hodgkin's disease, characterized by the presence of Reed-Sternberg cells. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma has a bimodal age distribution, and involves primarily lymph nodes. Current therapy for Hodgkin lymphoma has resulted in an excellent outcome and cure for the majority of patients.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C9357:C9305:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hodgkin Lymphoma","conceptCode":"C9357","definition":"A lymphoma characterized by the presence of relatively few malignant cells called Reed-Sternberg cells and mononuclear Hodgkin cells that are admixed with nonneoplastic inflammatory cells. The malignant cells have a distinctive immunophenotype; they are positive for CD30 and CD15 and negative for CD3, CD20, and CD45.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6270877-4C88-051A-E040-BB89AD4345BF","latestVersionIndicator":"Yes","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"ONEDATA","dateModified":"2012-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6270877-4C99-051A-E040-BB89AD4345BF","latestVersionIndicator":"Yes","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3537119","version":"1","preferredName":"Hodgkin Lymphoma  Malignant Neoplasm Diagnosis Category","preferredDefinition":"List of protocol defined categories specifically related to a patient's Hodgkin Lymphoma diagnosis.","longName":"3537119v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"advanced stage","valueDescription":"advanced stage (III or IV) relapse less than one year from the end of initial therapy","ValueMeaning":{"publicId":"3537120","version":"1","preferredName":"advanced stage (III or IV) relapse less than one year from the end of initial therapy","longName":"3537120","preferredDefinition":"advanced stage (III or IV) relapse less than one year from the end of initial therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6270877-4E5A-051A-E040-BB89AD4345BF","latestVersionIndicator":"Yes","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6270877-4E73-051A-E040-BB89AD4345BF","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"ONEDATA","dateModified":"2012-07-31","deletedIndicator":"No"},{"value":"very early relapse","valueDescription":"very early relapse (less than 6 months from the end of initial therapy including chemotherapy  with or without  radiation)","ValueMeaning":{"publicId":"3537121","version":"1","preferredName":"very early relapse (less than 6 months from the end of initial therapy including chemotherapy  with or without  radiation)","longName":"3537121","preferredDefinition":"very early relapse (less than 6 months from the end of initial therapy including chemotherapy  with or without  radiation)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6270877-4E7D-051A-E040-BB89AD4345BF","latestVersionIndicator":"Yes","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6270877-4E96-051A-E040-BB89AD4345BF","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"ONEDATA","dateModified":"2012-07-31","deletedIndicator":"No"},{"value":"primary refractory disease","valueDescription":"primary refractory disease (i.e. no prior CR)","ValueMeaning":{"publicId":"3537122","version":"1","preferredName":"primary refractory disease (i.e. no prior CR)","longName":"3537122","preferredDefinition":"primary refractory disease (i.e. no prior CR)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6270877-4EA0-051A-E040-BB89AD4345BF","latestVersionIndicator":"Yes","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6270877-4EB9-051A-E040-BB89AD4345BF","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"ONEDATA","dateModified":"2012-07-31","deletedIndicator":"No"},{"value":"advanced stage at diagnosis","valueDescription":"advanced stage (III or IV) at diagnosis who relapse less than one year from the end of initial therapy","ValueMeaning":{"publicId":"4695671","version":"1","preferredName":"advanced stage (III or IV) at diagnosis who relapse less than one year from the end of initial therapy","longName":"4695671","preferredDefinition":"advanced stage (III or IV) at diagnosis who relapse less than one year from the end of initial therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0DE26FC6-82BA-14E9-E050-BB89AD435593","latestVersionIndicator":"Yes","beginDate":"2015-01-30","endDate":null,"createdBy":"WANGC","dateCreated":"2015-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0DE26FC6-82D3-14E9-E050-BB89AD435593","beginDate":"2015-01-30","endDate":null,"createdBy":"WANGC","dateCreated":"2015-01-30","modifiedBy":"ONEDATA","dateModified":"2015-01-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6270877-4E44-051A-E040-BB89AD4345BF","latestVersionIndicator":"Yes","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"WANGC","dateModified":"2015-01-30","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Hodgkin Lymphoma category at","type":"Preferred Question Text","description":"Hodgkin Lymphoma category at enrollment","url":null,"context":"CTEP"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D427357C-7EC1-B804-E040-BB89AD4340DD","latestVersionIndicator":"Yes","beginDate":"2013-01-25","endDate":null,"createdBy":"MATTHEWK","dateCreated":"2013-01-25","modifiedBy":"SBR","dateModified":"2014-01-02","changeDescription":"Reversioned DE short name on 1/25/13 KM Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}